This opportunity is no longer accepting applications.
grant RFA-AG-25-010

Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)

This grant opportunity seeks applications to conduct clinical trials (Phase Ib to III) on potential treatments, including both drug-based and non-drug approaches, aimed at preventing, delaying, or alleviating symptoms of Alzheimer's disease and other dementias. The trials will utilize the Alzheimer's disease Clinical Trials Consortium (ACTC) for coordination and management.

This Notice of Funding Opportunity (NOFO) invites applications to develop and implement multi-site Phase Ib to III clinical trials of promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat the symptoms of Alzheimer's disease (AD) and other age-related d…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Open for Submission: July 1, 2024
Submission Deadline: October 17, 2024
Application Window Closes: October 17, 2024
Opportunity Released: July 1, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.